1. Market Research
  2. > Healthcare Market Trends
  3. > United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2016

United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2016

  • January 2016
  • -
  • Business Monitor International
  • -
  • 97 pages

Includes 3 FREE quarterly updates

BMI View: The UAE will continue to be an attractive emerging market for pharmaceutical companies as aresult of continued investment into the country's healthcare sector The rising prevalence of chronicdiseases, such as diabetes, is prompting both the public and private sector to improve the population'saccess to healthcare services - this will act as the main driver of pharmaceutical expenditure in the UAEHowever, during this period of oil price-driven austerity, the government is more likely to cut backspending on higher-value innovative drugs, posing a risk to multinational drugmakers

Headline Expenditure Projections

- Pharmaceuticals: AED946bn (USD258bn) in 2014 to AED1032bn (USD281bn) in 2015; +91% inlocal currency terms and +92% US dollar terms Forecast unchanged from last quarter

- Healthcare: AED4988bn (USD1358bn) in 2014 to AED5264bn (USD1434bn) in 2015; +55% inlocal currency terms and 56% in US dollar terms Forecast revised upwards from last quarter

Table Of Contents

United Arab Emirates Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (United Arab Emirates 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Arab Emirates 2011-2019) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Arab Emirates 2011-2019) 19
Prescription Drug Market Forecast 20
Table: UAE Healthcare Demand Split By Therapeutic Area 21
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 23
Patented Drug Market Forecast 24
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 28
OTC Medicine Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Arab Emirates 2011-2019) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (United Arab Emirates 2013-2019) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (United Arab Emirates 2013-2019) 34
Industry Risk/Reward Index 35
Middle East and Africa Risk/Reward Index - Q1 2016 35
United Arab Emirates Risk/Reward Index 43
Rewards 43
Risks 43
Regulatory Review 45
Regulatory Regime 45
Regulatory Developments 46
Pharmacovigilance 46
Pharmaceutical Advertising 47
Intellectual Property Issues 47
Pricing Regime 50
Pricing And Reimbursement Developments 51
Regional Harmonisation 53
Market Overview 57
Epidemiology 57
Table: UAE Healthcare Demand Split By Therapeutic Area 59
Healthcare Sector 59
Healthcare Sector Developments 61
Table: Healthcare Resources (United Arab Emirates 2009-2014) 64
Table: Healthcare Personnel (United Arab Emirates 2009-2014) 64
Table: Healthcare Activity (United Arab Emirates 2009-2014) 65
Health Insurance 65
Medical Tourism 67
Research and Development 69
Clinical Trials 71
Competitive Landscape 72
Pharmaceutical Sector 72
Table: Abu Dhabi's Top Five Best Selling Drugs In Value Terms By Therapeutic Area 72
Domestic Industry 73
Foreign Industry 75
Recent Company Developments 76
Table: Table: Multinational Market Activity 76
Pharmaceutical Distribution And Retail 77
Recent Developments 78
Company Profile 79
Gulf Pharmaceutical Industries (Julphar) 79
Neopharma 83
Demographic Forecast 86
Demographic Outlook 86
Table: Population Headline Indicators (United Arab Emirates 1990-2025) 87
Table: Key Population Ratios (United Arab Emirates 1990-2025) 87
Table: Urban/Rural Population and Life Expectancy (United Arab Emirates 1990-2025) 88
Table: Population By Age Group (United Arab Emirates 1990-2025) 88
Table: Population By Age Group % (United Arab Emirates 1990-2025) 89
Glossary 91
Methodology 93
Pharmaceutical Expenditure Forecast Model 93
Healthcare Expenditure Forecast Model 93
Notes On Methodology 94
Risk/Reward Index Methodology 95
Index Overview 96
Table: Pharmaceutical Risk/Reward Index Indicators 96
Indicator Weightings 97

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


Download Unlimited Documents from Trusted Public Sources

Eye Disease Statistics in the UK

  • December 2016
    9 pages
  • Eye Disease  

    Ophthalmology  

  • United Kingdom  

View report >

Veterinary Healthcare Supply in the US

  • November 2016
    3 pages
  • Veterinary Heal...  

    Agriculture  

  • United States  

View report >

Pathology Statistics in Belgium

  • November 2016
    12 pages
  • Pathology  

    Infectious Dise...  

  • Belgium  

    Europe  

    Syrian Arab Rep...  

View report >

Related Market Segments :

Healthcare
Pharmaceutical

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.